Check pharmacology, toxicology and pharmaceutics papers: citations, claims and retractions

Clinical pharmacokinetics of thalidomide

Teo, S. K., Colburn, W. A., Tracewell, W. G., Kook, K. A., Stirling, D. I., Jaworsky, M. S., Scheffler, M. A., Thomas, S. D., & Laskin, O. L. (2004) · Clinical Pharmacokinetics

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 150

Incorporation of protein flexibility and conformational energy penalties in docking screens to improve ligand discovery.

Fischer, M., Coleman, R. G., Fraser, J. S., & Shoichet, B. K. (2014) · Nature Chemistry

Computational Drug Discovery MethodsProtein Structure and Dynamics

Cited by 149

A factor binding to the xenobiotic responsive element (XRE) of P-4501A1 gene consists of at least two helix-loop-helix proteins, Ah receptor and Arnt.

Matsushita, N., Sogawa, K., Ema, M., Yoshida, A., & Fujii-Kuriyama, Y. (1993) · Journal of Biological Chemistry

Pharmacogenetics and Drug MetabolismToxic Organic Pollutants Impact

Cited by 149

Cytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l -amino acid oxidase

Hiu, J. J., & Yap, M. K. K. (2020) · Biochemical Society Transactions

Venomous Animal Envenomation and StudiesHealthcare and Venom Research

Cited by 149

Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents

Lu, Y., Slomberg, D. L., & Schoenfisch, M. H. (2014) · Biomaterials

Advanced Drug Delivery SystemsAntimicrobial agents and applications

Cited by 149

Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands

Bisson, W. H., Koch, D. C., O’Donnell, E. F., Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., & Kolluri, S. K. (2009) · Journal of Medicinal Chemistry

Computational Drug Discovery MethodsToxic Organic Pollutants Impact

Cited by 149

The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials

Harding, S. D., Armstrong, J. F., Faccenda, E., Southan, C., Alexander, S. P. H., Davenport, A. P., Pawson, A. J., Spedding, M., Davies, J. A., & NC-IUPHAR (2022) · Nucleic Acids Research

Computational Drug Discovery MethodsSARS-CoV-2 and COVID-19 Research

Cited by 149

Predicting the effect of cytochrome P450 inhibitors on substrate drugs: Analysis of physiologically based pharmacokinetic modeling submissions to the US Food and Drug Administration

Wagner, C., Pan, Y., Hsu, V., Grillo, J. A., Zhang, L., Reynolds, K. S., Sinha, V., & Zhao, P. (2015) · Clinical Pharmacokinetics

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 148

Nose-to-brain delivery of insulin enhanced by a nanogel carrier

Picone, P., Sabatino, M. A., Ditta, L. A., Amato, A., San Biagio, P. L., Mulè, F., Giacomazza, D., Dispenza, C., & Di Carlo, M. (2018) · Journal of Controlled Release

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 148

Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma: CYP3A4 induction by mitotane

Kroiss, M., Quinkler, M., Lutz, W. K., Allolio, B., & Fassnacht, M. (2011) · Clinical Endocrinology

Pharmacogenetics and Drug MetabolismAdrenal and Paraganglionic Tumors

Cited by 148

2P2Idb: a structural database dedicated to orthosteric modulation of protein–protein interactions

Basse, M. J., Betzi, S., Bourgeas, R., Bouzidi, S., Chetrit, B., Hamon, V., Morelli, X., & Roche, P. (2012) · Nucleic Acids Research

Computational Drug Discovery MethodsProtein Structure and Dynamics

Cited by 148

Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays

Shah, F., Leung, L., Barton, H. A., Will, Y., Rodrigues, A. D., Greene, N., & Aleo, M. D. (2015) · Toxicological Sciences

Drug-Induced Hepatotoxicity and ProtectionAnimal testing and alternatives

Cited by 148

Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability

Maderuelo, C., Lanao, J. M., & Zarzuelo, A. (2019) · European Journal of Pharmaceutical Sciences

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 147

Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex

Riad, A., Zeng, C., Weng, C.-C., Winters, H., Xu, K., Makvandi, M., Metz, T., Carlin, S., & Mach, R. H. (2018) · Scientific Reports

Pharmacological Receptor Mechanisms and EffectsCholesterol and Lipid Metabolism

Cited by 147

Nanoparticles Coated with High Molecular Weight PEG Penetrate Mucus and Provide Uniform Vaginal and Colorectal Distribution in Vivo

Maisel, K., Reddy, M., Xu, Q., Chattopadhyay, S., Cone, R., Ensign, L. M., & Hanes, J. (2016) · Nanomedicine

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 147

Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary history

Sabbagh, A., Langaney, A., Darlu, P., Gérard, N., Krishnamoorthy, R., & Poloni, E. S. (2008) · BMC Genetics

Pharmacogenetics and Drug MetabolismForensic and Genetic Research

Cited by 147

Cancer Risk Associated with Lorcaserin — The FDA’s Review of the CAMELLIA-TIMI 61 Trial

Sharretts, J., Galescu, O., Gomatam, S., Andraca-Carrera, E., Hampp, C., & Yanoff, L. (2020) · New England Journal of Medicine

Pharmacovigilance and Adverse Drug ReactionsPharmacology and Obesity Treatment

Cited by 147

Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19

Wang, J., Liu, Z., Wang, W., Chen, X., Shu, Y., He, N., & Zhou, H. (2001) · Clinical Pharmacology & Therapeutics

Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology

Cited by 147

Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework

Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology

Forensic Toxicology and Drug AnalysisOpioid Use Disorder Treatment

Cited by 146

From “Special K” to “Special M”: The Evolution of the Recreational Use of Ketamine and Methoxetamine

Corazza, O., Assi, S., & Schifano, F. (2013) · CNS Neuroscience & Therapeutics

Forensic Toxicology and Drug AnalysisSubstance Abuse Treatment and Outcomes

Cited by 146

Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components

Chatterjee, P., & Franklin, M. R. (2003) · Drug Metabolism and Disposition

Pharmacogenetics and Drug MetabolismComplementary and Alternative Medicine Studies

Cited by 146

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

McDonagh, E. M., Boukouvala, S., Aklillu, E., Hein, D. W., Altman, R. B., & Klein, T. E. (2014) · Pharmacogenetics and Genomics

Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology

Cited by 146

Distribution of insulin in trigeminal nerve and brain after intranasal administration

Lochhead, J. J., Kellohen, K. L., Ronaldson, P. T., & Davis, T. P. (2019) · Scientific Reports

Advanced Drug Delivery SystemsBarrier Structure and Function Studies

Cited by 146

New biomimetic barrier Permeapad™ for efficient investigation of passive permeability of drugs

di Cagno, M., Bibi, H. A., & Bauer-Brandl, A. (2015) · European Journal of Pharmaceutical Sciences

Drug Solubulity and Delivery SystemsAdvancements in Transdermal Drug Delivery

Cited by 146